Form 4: Ultragenyx Pharmaceutical Inc. Executive Receives Stock Award

Theodore Alan Huizenga, SVP and Chief Accounting Officer of Ultragenyx Pharmaceutical Inc., reports the acquisition of 700 shares of common stock through a restricted stock unit (RSU) award.

Summary

• Theodore Alan Huizenga, SVP and Chief Accounting Officer at Ultragenyx Pharmaceutical Inc., filed a Form 4 on September 18, 2024.
• The filing reports the acquisition of 700 shares of Ultragenyx common stock on September 16, 2024, through an award of Restricted Stock Units (RSUs) under the company's 2023 Incentive Plan.
• The RSUs vest in equal installments over four years, with 1/4th of the shares vesting on each anniversary of the grant date.
• Following the reported transaction, Huizenga beneficially owns 42,251 shares of Ultragenyx common stock, including previously reported shares underlying RSUs subject to vesting conditions.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral positive.

Positives

• The RSU award aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the executive.

Future Outlook

The vesting schedule of the RSUs implies a continued relationship between the executive and the company for at least four years.

Industry Context

Stock awards are a common form of executive compensation in the pharmaceutical industry, used to incentivize performance and retain key personnel.

Comparison to Industry Standards

• Executive compensation packages, including stock awards, are typically benchmarked against peer companies in the biotechnology and pharmaceutical sectors.
• Companies like BioMarin Pharmaceutical, Sarepta Therapeutics, and Vertex Pharmaceuticals also utilize stock options and RSUs as part of their executive compensation plans.
• The vesting schedules and grant sizes are often determined based on industry standards and individual performance.

Stakeholder Impact

• The RSU award could have a minor positive impact on shareholder sentiment, as it aligns executive interests with company performance.
• The award incentivizes the executive to contribute to the company's success, potentially benefiting employees and other stakeholders.

Key Dates